OMEGA HEALTHCARE INVESTORS INC (OHI) Form 8-K — Jul 29, 2026
Omega Healthcare Investors reported strong second quarter 2026 results, with Adjusted Funds From Operations (AFFO) of $0.83 per share, up from $0.77 in the prior year period. The company raised its full-year 2026 AFFO guidance to a range of $3.22 to $3.26 per share, citing accretive investment activity and active portfolio management. The company completed $126 million in new investments during the quarter and significantly expanded its partnership with Saber Healthcare. Additionally, Omega sold 26 facilities for $562.6 million in gross proceeds, recognizing a gain of $246.5 million, which bolstered its balance sheet and allowed for further capital deployment.
Key figures
- Eps
- 1.19
- Fad
- 0.78
- Affo
- 0.83
- Revenue
- 328246000
- Guidance
- $3.22 to $3.26
- Net Income
- 379668000
- Total Debt
- 4100000000
- Cash Position
- 39036000
- Offering Price
- 0
- Shares Outstanding
- 299111000
- Q2 asset sales
- $562.6 million
- Q2 investments
- $126.5 million
- Q2 dividend declared
- $0.68
Price after filing
Close on the filing date to close N calendar days later (from $51.40). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.